Effects of ezetimibe/simvastatin 10/10 mg versus Rosuvastatin 10 mg on carotid atherosclerotic plaque inflammation
Abstract Background Using 18F-fluorodeoxyglucose (18FDG) positron emission tomography-computed tomography (PET/CT) imaging, we examined the effects of ezetimibe/simvastatin 10/10 mg versus rosuvastatin 10 mg on carotid atherosclerotic plaque inflammation. Whether the combination therapy of ezetimibe...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-08-01
|
Series: | BMC Cardiovascular Disorders |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12872-019-1184-2 |
id |
doaj-25d3776b7e9c4a9491673de202fbc6cc |
---|---|
record_format |
Article |
spelling |
doaj-25d3776b7e9c4a9491673de202fbc6cc2020-11-25T03:17:07ZengBMCBMC Cardiovascular Disorders1471-22612019-08-011911710.1186/s12872-019-1184-2Effects of ezetimibe/simvastatin 10/10 mg versus Rosuvastatin 10 mg on carotid atherosclerotic plaque inflammationMinyoung Oh0Hyunji Kim1Eon Woo Shin2Changhwan Sung3Do-Hoon Kim4Dae Hyuk Moon5Cheol Whan Lee6Department of Nuclear Medicine, Asan Medical Center, University of Ulsan College of MedicineDepartment of Nuclear Medicine, Asan Medical Center, University of Ulsan College of MedicineDepartment of Nuclear Medicine, Asan Medical Center, University of Ulsan College of MedicineDepartment of Nuclear Medicine, Asan Medical Center, University of Ulsan College of MedicineDepartment of Nuclear Medicine, Asan Medical Center, University of Ulsan College of MedicineDepartment of Nuclear Medicine, Asan Medical Center, University of Ulsan College of MedicineDivision of Cardiology, Heart Institute, Asan Medical Center, University of Ulsan College of MedicineAbstract Background Using 18F-fluorodeoxyglucose (18FDG) positron emission tomography-computed tomography (PET/CT) imaging, we examined the effects of ezetimibe/simvastatin 10/10 mg versus rosuvastatin 10 mg on carotid atherosclerotic plaque inflammation. Whether the combination therapy of ezetimibe with low-dose statin is as effective as potent statin monotherapy in attenuating carotid atherosclerotic plaque inflammation remains unclear. Methods In this 2-by-2 factorial trial, 50 patients with 18FDG uptake (target-to-background ratio [TBR] ≥1.6) in the carotid artery and acute coronary syndrome were randomized to receive either simvastatin/ezetimibe 10/10 mg or rosuvastatin 10 mg. 18FDG PET/CT examinations were performed at baseline and at 6 months. The percent change in the TBR of the index vessel at the most diseased segment (MDS) was the primary endpoint. Results Baseline characteristics of the two groups were largely similar. At 6-month follow-up, the MDS TBR of the index vessel and aorta significantly decreased in ezetimibe/simvastatin group and tended to decrease in rosuvastatin group. However, the percent change in the MDS TBR of the index vessel was similar between the 2 groups (− 10.22 ± 17.49% vs. -5.84 ± 15.78%, respectively, p = 0.357), as was the percent change in the whole vessel TBR of the index vessel. Likewise, the changes in the MDS TBR or whole vessel TBR of the aorta were similar in both groups. Total cholesterol and low-density lipoprotein cholesterol levels improved to a similar degree in both groups. Conclusion Treatment with ezetimibe/simvastatin versus rosuvastatin resulted in a similar improvement of carotid atherosclerotic plaque inflammation, suggesting their equivalent anti-inflammatory effects. Trial registration The trial is registered at ClinicalTrials.gov: NCT02378064, 3-4-2015. /IRB No. 2015–0194.http://link.springer.com/article/10.1186/s12872-019-1184-2EzetimibePlaque inflammationStatinPositron emission tomography |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Minyoung Oh Hyunji Kim Eon Woo Shin Changhwan Sung Do-Hoon Kim Dae Hyuk Moon Cheol Whan Lee |
spellingShingle |
Minyoung Oh Hyunji Kim Eon Woo Shin Changhwan Sung Do-Hoon Kim Dae Hyuk Moon Cheol Whan Lee Effects of ezetimibe/simvastatin 10/10 mg versus Rosuvastatin 10 mg on carotid atherosclerotic plaque inflammation BMC Cardiovascular Disorders Ezetimibe Plaque inflammation Statin Positron emission tomography |
author_facet |
Minyoung Oh Hyunji Kim Eon Woo Shin Changhwan Sung Do-Hoon Kim Dae Hyuk Moon Cheol Whan Lee |
author_sort |
Minyoung Oh |
title |
Effects of ezetimibe/simvastatin 10/10 mg versus Rosuvastatin 10 mg on carotid atherosclerotic plaque inflammation |
title_short |
Effects of ezetimibe/simvastatin 10/10 mg versus Rosuvastatin 10 mg on carotid atherosclerotic plaque inflammation |
title_full |
Effects of ezetimibe/simvastatin 10/10 mg versus Rosuvastatin 10 mg on carotid atherosclerotic plaque inflammation |
title_fullStr |
Effects of ezetimibe/simvastatin 10/10 mg versus Rosuvastatin 10 mg on carotid atherosclerotic plaque inflammation |
title_full_unstemmed |
Effects of ezetimibe/simvastatin 10/10 mg versus Rosuvastatin 10 mg on carotid atherosclerotic plaque inflammation |
title_sort |
effects of ezetimibe/simvastatin 10/10 mg versus rosuvastatin 10 mg on carotid atherosclerotic plaque inflammation |
publisher |
BMC |
series |
BMC Cardiovascular Disorders |
issn |
1471-2261 |
publishDate |
2019-08-01 |
description |
Abstract Background Using 18F-fluorodeoxyglucose (18FDG) positron emission tomography-computed tomography (PET/CT) imaging, we examined the effects of ezetimibe/simvastatin 10/10 mg versus rosuvastatin 10 mg on carotid atherosclerotic plaque inflammation. Whether the combination therapy of ezetimibe with low-dose statin is as effective as potent statin monotherapy in attenuating carotid atherosclerotic plaque inflammation remains unclear. Methods In this 2-by-2 factorial trial, 50 patients with 18FDG uptake (target-to-background ratio [TBR] ≥1.6) in the carotid artery and acute coronary syndrome were randomized to receive either simvastatin/ezetimibe 10/10 mg or rosuvastatin 10 mg. 18FDG PET/CT examinations were performed at baseline and at 6 months. The percent change in the TBR of the index vessel at the most diseased segment (MDS) was the primary endpoint. Results Baseline characteristics of the two groups were largely similar. At 6-month follow-up, the MDS TBR of the index vessel and aorta significantly decreased in ezetimibe/simvastatin group and tended to decrease in rosuvastatin group. However, the percent change in the MDS TBR of the index vessel was similar between the 2 groups (− 10.22 ± 17.49% vs. -5.84 ± 15.78%, respectively, p = 0.357), as was the percent change in the whole vessel TBR of the index vessel. Likewise, the changes in the MDS TBR or whole vessel TBR of the aorta were similar in both groups. Total cholesterol and low-density lipoprotein cholesterol levels improved to a similar degree in both groups. Conclusion Treatment with ezetimibe/simvastatin versus rosuvastatin resulted in a similar improvement of carotid atherosclerotic plaque inflammation, suggesting their equivalent anti-inflammatory effects. Trial registration The trial is registered at ClinicalTrials.gov: NCT02378064, 3-4-2015. /IRB No. 2015–0194. |
topic |
Ezetimibe Plaque inflammation Statin Positron emission tomography |
url |
http://link.springer.com/article/10.1186/s12872-019-1184-2 |
work_keys_str_mv |
AT minyoungoh effectsofezetimibesimvastatin1010mgversusrosuvastatin10mgoncarotidatheroscleroticplaqueinflammation AT hyunjikim effectsofezetimibesimvastatin1010mgversusrosuvastatin10mgoncarotidatheroscleroticplaqueinflammation AT eonwooshin effectsofezetimibesimvastatin1010mgversusrosuvastatin10mgoncarotidatheroscleroticplaqueinflammation AT changhwansung effectsofezetimibesimvastatin1010mgversusrosuvastatin10mgoncarotidatheroscleroticplaqueinflammation AT dohoonkim effectsofezetimibesimvastatin1010mgversusrosuvastatin10mgoncarotidatheroscleroticplaqueinflammation AT daehyukmoon effectsofezetimibesimvastatin1010mgversusrosuvastatin10mgoncarotidatheroscleroticplaqueinflammation AT cheolwhanlee effectsofezetimibesimvastatin1010mgversusrosuvastatin10mgoncarotidatheroscleroticplaqueinflammation |
_version_ |
1724633324057526272 |